Evidence map›Paper›PMID 11973646›Full record

ArticleOncogene2002

The v-erbA oncogene blocks expression of alpha2/beta1 integrin a normal inhibitor of erythroid progenitor proliferation.

Anne Mey, Olivier Gandrillon, Kelly M McNagny, Dennis O Clegg, Jacques Samarut

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Anne MeyLaboratoire de Biologie Moléculaire et Cellulaire, CNRS UMR 5665, Ecole Normale Supérieure de Lyon, 46 allée d'Italie, 69008 Lyon, France.
Olivier Gandrillon
Kelly M McNagny
Dennis O Clegg
Jacques Samarut
École Normale Supérieure de Lyon · FRCentre National de la Recherche Scientifique · FRUniversity of British Columbia · CAUniversity of California, Santa Barbara · US

Funding

RETINAL RECEPTORS FOR DEVELOPMENT CUESR01EY009736 · NEI · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI CLEGG, DENNIS O · 1994 to 2000
$188k
NEI NIH HHS EY 09736
6 · The paper itself

Abstract

T2EC are chicken erythrocytic progenitors that balance between self-renewal and differentiation as a function of response to specific growth factors. Their transformation by the v-erbA oncogene locks them into the self-renewal program. We show here that the expression of the VLA-2 integrin alpha2 subunit mRNA is downregulated by v-erbA and that VLA-2 engagement and clustering, brought about by treatment with an alpha2-specific antibody or by culture on the VLA-2 ligand collagen I, inhibits T2EC proliferation. From competition studies using antibodies, VLA-2 was shown to be involved in the collagen-induced response. While engagement of VLA-2 inhibited proliferation, it was not sufficient to induce differentiation. The transformation of T2EC by v-erbA decreased their interaction with collagen I and the VLA-2 brake on cell proliferation, which may account for the increased proliferation potential of transformed erythrocytic progenitors and for their shedding into the blood of infected chickens. Our data suggest that the interaction between erythroid progenitors and collagen, mediated by VLA-2, play a major role in the control of erythropoiesis in vitro and that this pathway is a target of the v-erbA oncogene.

Indexed as

Down-RegulationAnimalsAntibodies, MonoclonalCations, DivalentCell AdhesionCell DivisionCell LineChickensCollagenCollagen Type IErythrocytesExtracellular MatrixFibronectinsHematopoietic Stem CellsIntegrinsOncogene Proteins v-erbAAntibodies, MonoclonalCations, DivalentCollagenCollagen Type IFibronectinsIntegrinsOncogene Proteins v-erbAReceptors, Collagen

Identifiers

PMID11973646
OpenAlexW2322610886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.